---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-046587"
form_type: "8-K"
ticker: "IMNN"
cik: "0000749647"
company_name: "Imunon, Inc."
filed_at: "2023-12-29T23:59:59+00:00"
generated_at: "2026-06-07T06:10:23.357975+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Imunon receives Nasdaq deficiency notice for bid price below $1.00 per share

## Summary
- Received Nasdaq deficiency letter on Dec. 26, 2023; bid price closed below $1.00 for 30 consecutive business days.
- Given 180-day cure period until June 24, 2024; must have bid price >=$1.00 for 10 consecutive business days.
- If not compliant by June 24, 2024, may be eligible for second 180-day compliance period subject to other listing standards.
- Failure to cure could result in delisting; company may appeal any delisting determination.
- No immediate effect on listing; shares continue trading on Nasdaq Capital Market under IMNN.

## SEC filing metadata
- accession: 0001493152-23-046587
- form_type: 8-K
- ticker: IMNN
- cik: 0000749647
- company_name: Imunon, Inc.
- filed_at: 2023-12-29T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/749647/000149315223046587/0001493152-23-046587-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/749647/000149315223046587/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-046587
- JSON: https://secwatch.observer/filing/0001493152-23-046587.json
- Plain text: https://secwatch.observer/filing/0001493152-23-046587.txt

## Key facts
- Listing & Compliance Notices
  Imunon, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2)
  source text: December 26, 2023, Imunon, Inc. (“the Company”) received a letter from the staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) providing notification that, for the previous 30 consecutive business days, the bid price for the Company’s common stock had closed below the minimum $1.00 per share requirement for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2). Nasdaq’s notice has no immediate effect on the listing of the Company’s common stock on The Nasdaq Capital Market, which continues to trade under the symbol “IMNN”. In accordance with Nasdaq Listi
  evidence_url: https://www.sec.gov/Archives/edgar/data/749647/000149315223046587/0001493152-23-046587-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.